Latest Options News

SportsHero Limited has raised $4.3 million through a private placement, including a significant commitment from its CEO, to accelerate its HeroPlay rollout across Southeast Asia.

Kaiser Reef Limited has raised its production target at the Henty Gold Mine to 35,000 ounces per annum by late FY2027 while accelerating exploration and development activities at its Maldon Gold Project, all funded through operational cash flow.

Genesis Minerals Limited has announced a recommended scheme to acquire Magnetic Resources NL, bringing a high-grade 2.2 million ounce gold resource near its Laverton mill and offering Magnetic shareholders a compelling premium with a mix of cash and shares.

Galilee Energy has launched an offer of up to 464 million new options to participants in its recent $6.5 million placement, aiming to bolster exploration funding and working capital. The options, exercisable at $0.011 each over three years, come amid significant operational and market risks.

Global Uranium and Enrichment Limited has been fully acquired by Snow Lake Resources through a share and option scheme, leading to GUE's imminent delisting from the ASX.

Katana Capital Limited has reported a remarkable 672% increase in half-year profit after tax to $5.8 million, driven by strong investment income and gains. The company maintains its quarterly dividend at 0.5 cents per share, reflecting confidence in its ongoing strategy.

Lithium Energy Limited is set to begin a 2,700-metre drilling campaign at its Sandy Creek Gold-Copper Prospect following rock chip samples revealing significant copper, gold, and silver grades. This marks a key step in exploring the Capricorn Gold-Copper Belt Project near the historic Mt Morgan mine.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

Felix Gold Limited has confirmed significant extensions to gold mineralisation at its NW Array prospect in Alaska's Treasure Creek, with high-grade assay results and broad gold halos around antimony veins. The mineralised system remains open for further expansion, supporting the company's dual-commodity strategy.

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

Regal Asian Investments Limited (ASX, RG8) has updated its Dividend Reinvestment Plan, eliminating the minimum participation requirement and streamlining administrative processes for shareholders.